ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO816

KLF4 Promotes Gd-IgA1 Synthesis in B Cells of IgA Nephropathy

Session Information

Category: Glomerular Diseases

  • 1401 Glomerular Diseases: Mechanisms, including Podocyte Biology

Authors

  • Gan, Yangang, Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China
  • Yang, Qiongqiong, Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China
  • Hao, Li, Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China
  • Li, Jiajia, Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China
  • Li, Wenchao, Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China
  • Yu, Hao, Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China
  • Zeng, Weicong, Sun Yat-Sen Memorial Hospital, Guangzhou, Guangdong, China
Background

B cells are thought to perform a crucial function in IgA nephropathy (IgAN) pathogenesis by generating abnormal IgA1 and antibodies. Nonetheless, the machinery behind the aberrant gene expression of B cells in IgAN patients remains ambiguous.

Methods

This study has revealed an extensive range of differences in chromatin accessibility within the B cells of IgAN via ATAC-seq evaluation of active DNA regulatory components.

Results

B cells of IgAN were noted to display enhanced chromatin accessibility in genes affiliated with transcription regulation. Moreover, KLF4 was also recognized as a crucial transcription factor supporting the generation of IgA1 and galactose-deficient IgA1 (Gd-IgA1). In vitro, the knockdown of KLF4 suppressed the production of Gd-IgA1 in IgA-secreting cell lines. The study further showed that KLF4 could regulate the expression of genes related to the intestinal immune network for IgA production through RNA-seq. Combining ChIP-seq and RNA-seq, it was found that KLF4 can bind to the IL-6 promoter and regulate its expression. Mechanistically, a luciferase reporter assay verified that KLF4 directly binds to the cis-regulatory element of IL-6 and promotes its expression. KLF4 knockdown has been demonstrated to mitigate renal lesions and mesangial hypercellularity in IgAN mice.

Conclusion

Findings from this study reveal a mechanism mediated by chromatin underlying the differential responses of B cells in IgAN and identify KLF4 as a potential therapeutic target of IgAN.

Funding

  • Government Support – Non-U.S.